Repurposing Initiatives Proposed To Unlock ‘Untapped Potential’ In Europe
Medicines For Europe Report Urges Action To Bolster Value Added Medicines
Earlier industry involvement in repurposing activities and a more tailored European regulatory environment for value added medicines are among the proposals set out in a new report published by Medicines for Europe. The association has also suggested creating an “indications pool” to act as a central repository for repurposing information generated by not-for-profit and academic organizations through a STAMP pilot project.
